
Immuneering Corp (IMRX) Earnings Dates & Reports
Immuneering Corp (IMRX) Most Recent Earnings
Report DateMay 5, 2025
Period EndingQ1 2025
Est. EPS-$0.58
Actual EPS-$0.42
EarningsBeat
Immuneering Corp (IMRX) Earnings
View the latest Immuneering Corp (IMRX) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Immuneering Corp (IMRX)
Order type
Buy in
Order amount
Est. shares
0 shares
Immuneering Corp (IMRX) Earnings per Share (EPS) History
Signup for full accessBrowse free
Immuneering Corp (IMRX) Latest Earnings
The value each IMRX share was expected to gain vs. the value each share gained.
Immuneering Corp (IMRX) reported its most recent earnings on May 5, 2025 for Q1 2025, posting earnings per share (EPS) of -$0.42. This exceeded analysts' expectations of -$0.58 by 27.59%, marking a Beat.
For comparison, Immuneering Corp reported EPS of -$0.49 in the same quarter last year.
The company is expected to announce its next earnings report on 08/05/2025, with analysts projecting an EPS of $0.
Immuneering Corp (IMRX) Earnings History
Earnings | Est. EPS | Actual EPS | Surprise | |
---|---|---|---|---|
Q2 2025Aug 5, 2025 | – | Next earnings call Aug. 5, 2025 | ||
Q1 2025May 5, 2025 | -$0.58 | -$0.42 | -27.59% | |
Q4 2024Mar 20, 2025 | -$0.47 | -$0.58 | +23.40% | |
Q3 2024Nov 13, 2024 | -$0.55 | -$0.49 | -10.91% | |
Q2 2024Aug 6, 2024 | -$0.52 | -$0.47 | -9.62% | |
Immuneering Corp (IMRX) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Immuneering Corp’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
May 5, 2025 | — | — | — |
Mar 20, 2025 | — | — | — |
Nov 13, 2024 | — | — | — |
Aug 6, 2024 | — | — | — |
Immuneering Corp (IMRX) Earnings FAQs
Immuneering Corp (IMRX) last reported earnings on May 5, 2025 for Q1 2025, posting an EPS of -$0.42, which Beat the estimate of -$0.58 by 27.59%.
For Q1 2025, Immuneering Corp (IMRX) reported an EPS of -$0.42, exceeding analysts' estimate of -$0.58 by 27.59%.
For Q1 2025, Immuneering Corp (IMRX) Beat expectations with an actual EPS of -$0.42 vs. an estimated EPS of -$0.58.
Following the last earnings report on May 5, 2025, Immuneering Corp (IMRX)'s stock price moved — from — to —.
The next Immuneering Corp (IMRX) earnings call is scheduled for Aug. 5, 2025, where executives will discuss financial results and outlook.